Back to 
Capital Research Global Investors
Capital Research Global Investors
CYTK2 quarters
Position history for Capital Research Global Investors's holdings in CYTOKINETICS INC
Capital Research Global Investors holds 1.7M shares of CYTK (CYTOKINETICS INC), worth $143.7M as of 2026-Q2. The position was increased (+118.8% shares). CYTK represents 0.0% of Capital Research Global Investors's portfolio.
Current Value
$143.7M
Current Shares
1.7M
Total Value Change
+$92.9M
Total Shares Change
+915,626
Quarter-by-Quarter History
Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.